<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<PRE>

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



       Date of Report (Date of earliest event reported): November 14, 2007


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



          Delaware                   1-14120                  52-1611421
(State or other jurisdiction (Commission File Number)    (I.R.S. Employer
      of incorporation)                                  Identification No.)


                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                                 Not Applicable
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))







<b>Item 2.02.  <u>Results of Operations and Financial Condition</u></b>

On November 14, 2007, Blonder Tongue  Laboratories,  Inc. issued a press release
announcing its unaudited financial results for the third quarter ended September
30, 2007. A copy of the press release is attached to this Report as Exhibit 99.1
and is  incorporated  herein by  reference.  The  information  disclosed in this
report,  including  Exhibit 99.1  hereto,  is being  furnished  and shall not be
deemed  "filed" for  purposes of Section 18 of the  Securities  Exchange  Act of
1934.

<b>Item 9.01.  <u>Financial Statements and Exhibits</u></b>

(a)      Not applicable


(b)      Not applicable


(c)      Not applicable


(d)      The following exhibits are filed herewith:


     Exhibit 99.1 Press Release dated November 14, 2007.








                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                    BLONDER TONGUE LABORATORIES, INC.



                                    By:<u>/s/ Eric Skolnik</u>
                                         Eric Skolnik
                                         Senior Vice President and
                                         Chief Financial Officer

Date: November 14, 2007







                                       2






                                  <b>EXHIBIT INDEX


         <u>Exhibit No.</u>                                 <u>Description</u></b>

         Exhibit 99.1         Press Release of Blonder Tongue Laboratories, Inc.
                              dated November 14, 2007 regarding its unaudited
                              financial results for the third quarter ended
                              September 30, 2007.


</PRE>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "blonder8k111307.htm", "secsgml_size_bytes": 3664}]
{"company-data": {"conformed-name": "BLONDER TONGUE LABORATORIES INC", "cik": "0001000683", "assigned-sic": "3663", "irs-number": "521611421", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-14120", "film-number": "071241125"}, "business-address": {"street1": "ONE JAKE BROWN RD", "street2": "PO BOX 1000", "city": "OLD BRIDGE", "state": "NJ", "zip": "08857", "phone": "9086794000"}, "mail-address": {"street1": "ONE JAKE BROWN ROAD", "city": "OLD BRIDGE", "state": "NJ", "zip": "08857"}}
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): November 14, 2007

                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)

          Delaware                   1-14120                  52-1611421
(State or other jurisdiction (Commission File Number)    (I.R.S. Employer
      of incorporation)                                  Identification No.)

                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (732) 679-4000

                                 Not Applicable
          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)

[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))
Item 2.02.
Results of Operations and Financial Condition
On November 14, 2007, Blonder Tongue  Laboratories,  Inc. issued a press release
announcing its unaudited financial results for the third quarter ended September
30, 2007. A copy of the press release is attached to this Report as Exhibit 99.1
and is  incorporated  herein by  reference.  The  information  disclosed in this
report,  including  Exhibit 99.1  hereto,  is being  furnished  and shall not be
deemed  "filed" for  purposes of Section 18 of the  Securities  Exchange  Act of
1934.
Item 9.01.
Financial Statements and Exhibits
(a)      Not applicable

(b)      Not applicable

(c)      Not applicable

(d)      The following exhibits are filed herewith:

     Exhibit 99.1 Press Release dated November 14, 2007.

                                    SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                    BLONDER TONGUE LABORATORIES, INC.

                                    By:
/s/ Eric Skolnik
Eric Skolnik
                                         Senior Vice President and
                                         Chief Financial Officer

Date: November 14, 2007

                                       2
EXHIBIT INDEX
Exhibit No.
Description
Exhibit 99.1         Press Release of Blonder Tongue Laboratories, Inc.
                              dated November 14, 2007 regarding its unaudited
                              financial results for the third quarter ended
                              September 30, 2007.